Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | PRKCA | P17252 | 2/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.33 |
| ▸ | PRKCG | P05129 | 1/20 | 0.33 |
| ▸ | PRKCB | P05771 | 1/20 | 0.33 |
| ▸ | PRKCH | P24723 | 1/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.33 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23036805 | 0.92 | ALOX15 (0.44) | ALOX15PRKCAMMP1MMP2MMP3 | |
| SCHEMBL21143367 | 0.84 | ADRA2A (0.43) | ALOX15CYP19A1ALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL21143391 | 0.84 | ALOX15 (0.42) | ALOX15CYP19A1ALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL3859719 | 0.83 | BLM (0.48) | ALOX15MMP1MMP2MMP3MMP9 | |
| SCHEMBL3508684 | 0.82 | MMP1 (0.37) | ALOX15PRKCAMMP1MMP2MMP3 | |
| SCHEMBL901332 | 0.81 | CYP19A1 (0.49) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL2529389 | 0.81 | MMP1 (0.42) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL113763 | 0.81 | CYP19A1 (0.49) | PRKCAMMP1MMP2MMP3MMP9 | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL21313284 | 0.81 | ALOX15 (0.35) | ALOX15CYP19A1ALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL21143373 | 0.81 | DGKA (0.42) | ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210228459-A1 | ESTERS AND ETHERS OF 3-METHYL-PENTANE-DIOL AND UNSATURATED DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICAL | BASF SE (DE) | 2021-07-29 | — | — | US | claimed |
| EP-3784762-A1 | ESTERS AND ETHERS OF 3-METHYL-PENTANE-DIOL AND UNSATURATED DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICAL | BASF SE (DE) | 2021-03-03 | — | — | EP | claimed |
| EP-3784762-B1 | ESTERS AND ETHERS OF 3-METHYL-PENTANE-DIOL AND UNSATURATED DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICAL | BASF SE (DE) | 2025-09-03 | — | — | EP | disclosed |
| US-20210228459-A1 | ESTERS AND ETHERS OF 3-METHYL-PENTANE-DIOL AND UNSATURATED DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICAL | BASF SE (DE) | 2021-07-29 | — | — | US | disclosed |
| EP-3784762-A1 | ESTERS AND ETHERS OF 3-METHYL-PENTANE-DIOL AND UNSATURATED DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICAL | BASF SE (DE) | 2021-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228459-A1 | ESTERS AND ETHERS OF 3-METHYL-PENTANE-DIOL AND UNSATURATED DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICAL | FFAR3, ELOVL3, ACMSD | ALOX15 74/4885PRKCA 3009/4885MMP1 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.